Capricor Therapeutics Inc (CAPR) Implied Volatility Current

Tracking CAPR implied volatility helps you identify when options premiums on Capricor Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Capricor Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when CAPR IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Capricor Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For CAPR, tracking metrics like CAPR IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on CAPR signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in development stage for the potential prevention of COVID-19.

It collaborates with Lonza Houston, Inc. for the clinical manufacturing of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in San Diego, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where CAPR implied volatility sits today versus where it has been. Our scanner ranks Capricor Therapeutics Inc implied volatility against its historical range, surfaces extremes in CAPR IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Capricor Therapeutics Inc IV is rich or cheap — measure it, then act on it.